Novo Nordisk A/S (NVO)
38.58
-0.49
(-1.25%)
USD |
NYSE |
Mar 06, 16:00
39.37
+0.79
(+2.05%)
After-Hours: 20:00
Novo Nordisk SG&A Expense (TTM) : 10.66B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ascendis Pharma A/S | 519.00M |
| Evaxion AS | 0.00 |
| Viking Therapeutics, Inc. | 48.39M |
| DBV Technologies SA | 28.71M |
| Cellectis SA | 19.93M |